C3AR1 and brain neoplasm: Daily i.p. injections (5 days on, 2 days off) of 1 mg/kg of the C3aR antagonist SB290157 were initiated at the time of emergence of brain tumor symptoms, with or without radiotherapy (10 Gy) (Figure 6A).